The Sirtuin family of proteins (SIRTs) encode a group of evolutionarily conserved, NAD-dependent histone deacetylases, involved in many biological pathways. SIRT1, the human homolog of the yeast Silent Information Regulator 2 (Sir2) gene, deacetylates histones, p300, 
Introduction
The sirtuin family consists of NAD + -dependent histone deacetylases (HDACs), conserved from archaeobacteria to eukaryotes, and classified as class III HDACs (1, 2) . The enzymatic activity of sirtuins is NAD + dependent and the Sirtuin family members (SIRT1-SIRT7), convey diverse functions (2) . SIRT1 is the mammalian ortholog of the Sir2 gene, an important regulator of aging in Saccharomyces Cerevisiae, Caenorhabditis Elegans, and Drosophila Melanogaster (3) . The role of SIRT1 in cellular growth control is complex and celltype specific. In vitro, SIRT1 inhibits p53, Bax, Ku70, FOXO, and the retinoblastoma (Rb)
protein (4, 5) , which may be anticipated to promote cell proliferation. Reduction in SIRT1 activity induced cell growth arrest and apoptosis in breast, lung, and colon cancer cells (5) (6) (7) .
Inhibition of SIRT1 with Sirtinol induced growth arrest in MCF7 and H1299 cells (5) . In contrast, several in vivo studies suggest that SIRT1 may function as a tumor suppressor as Sirt1 -/-mice show an impaired DNA damage response, evident by increased genomic instability and tumorigenesis (8) . Additional studies from Sirt1 -/-and transgenic mice are consistent with a role for Sirt1 in tumor suppression as Sirt1 was shown to suppress intestinal tumorigenesis and colon cancer (9) .
Androgen receptor (AR) expression and activity are key determinants of prostate cancer onset and progression. Of potential importance to prostate biology and function, SIRT1
deacetylates the histone acetyltransferase (HAT) p300 and the AR. SIRT1 transduction of ARexpressing prostate cancer cells (LNCaP) decreased cell proliferation and blocked contactindependent growth (10) . The AR colocalizes with SIRT1 in a nuclear sub-compartment, where SIRT1 binds to and deacetylates the AR, thereby inhibiting its activity (1, 11) . Histone acetyltransferases (p300, CBP/PCAF, Tip60) acetylate the AR at a conserved motif in response to dihydroxytestosterone (DHT), thereby stimulating the growth and anti-apoptotic functions of the AR. The AR lysine residues targeted by acetylation (K630, K632, K633) are well conserved between species and serve as substrates for SIRT1-mediated deacetylation (12, 13) , resulting in inhibition of ligand-induced AR activity (14) .
Prostate cancer proceeds via morphological changes transitioning from the development of prostatic intraepithelial neoplasia (PIN), invasive adenocarcinoma, and metastasis. The The role of SIRT1 in regulating prostate gland formation and androgen signaling in vivo was previously unknown. SIRT1 is expressed in several cell types in the prostate gland including basal cells, luminal cells, and stromal cells. Given the evidence that SIRT1 functions as a tissuespecific regulator of cellular growth and that SIRT1 inhibits tumor cell line growth in nude mice, we sought to determine the role of endogenous Sirt1 in regulating prostate gland development. Analysis of arrays was performed using the R statistics package (19) and the limma library (20) of the Bioconductor software package. Arrays were normalized using robust multiarray analysis (RMA), while a P-value of 0.05 and a fold change of at least 2 fold was applied as criteria for statistically differentially expressed genes. Gene Ontology (GO) analysis of gene functions was analyzed using "Webgestalt" (http://bioinfo.vanderbilt.edu/webgestalt).
Genes were clustered using hierarchical clustering with "complete" agglomeration. Each cluster was further analyzed based on the known function of the genes contained in the cluster.
Expression profiles are displayed using Treeview (21) . Pathway analysis was performed using Billerica, MA, 1:1000), and anti-GDIα (22) . Knockdown experiments were performed as previously described (23), (24) . siRNAs used included SIRT1 siRNA (Qiagen: SI00098434, Valencia, CA) and a validated, non-silencing control siRNA (Qiagen: 10227281). Quantitation 8 and normalization of immunoblotting results was performed as previously described (25) . 
Results

Sirt1 -/-Mice Develop Prostatic Intraepithelial Neoplasia
To examine the role of Sirt1 in the development of androgen-responsive tissues such as the prostate, Sirt1 -/-mice were examined. Genotyping was conducted as previously described (18) 1B,C). Individual organ weights were measured and normalized to the animal's body weight (Fig. 1D ). The ventrodorsolateral (VDL) and anterior prostates and the seminal vesicles were significantly decreased in size when normalized to total body weight ( Fig. 1D ). In contrast, the weight of the intestine and pancreas was unchanged ( stromal layer surrounding the epithelium (Fig. S1B) . The seminiferous tubules were dilated with a significant reduction in the number of mature sperm within the Sirt1 -/-mice (Fig. S1B ).
Sirt1 Governs Prostate Autophagy, Apoptosis, and Cell Proliferation Signaling Pathways
To examine the gene expression profile regulated by endogenous Sirt1, ventrodorsolateral prostate RNA from Sirt1 +/+ and Sirt1 -/-mice was compared. 498 genes were differentially regulated by Sirt1, with 146 mRNAs altered greater than two-fold ( Fig. 2A) . The biological pathways associated with this altered gene expression signature analyzed using Biocarta and the Kyoto Encyclopedia of Genes and Genomes (KEGG) demonstrated that endogenous Sirt1 regulates pathways governing the cell cycle, cell adhesion, diabetes, and immune function (Tables S1,S2 ). Comparisons made with published datasets of androgenresponsive genes identified in prostate cancer cell lines or within the prostate gland (Tables   S4A,B) , displayed an overlap between Sirt1-regulated and androgen-regulated genes as 12.45% of the genes regulated by Sirt1 were also previously reported to be androgen-responsive. Several genes induced by DHT in vitro correspond to genes repressed by Sirt1 in the prostate and similarly Sirt1 enhanced expression of several genes repressed by DHT. For other genes, directionality of expression changes by DHT and Sirt1 were concordant (Tables S3-S4B ). The highest proportion of genes coinciding with our data was found with in vivo data (22/498, 4.42%) rather than cultured prostate cancer cell lines (26) . This finding suggests that androgen signaling may differ between the in vivo and cultured cell environment.
Higher order structural analysis of the expression data was conducted using gene set enrichment analysis (GSEA) and Analysis of Sample Set Enrichment Scores (ASSESS) to identify discrete biological functions associated with cell signaling in our array. GSEA utilizes gene expression levels as a means to establish a set rank list of significantly regulated genes within compared sample populations. ASSESS refers to a measure of enrichment of the gene sets across multiple established and annotated gene sets (27) . Supervised clustering was employed and identified a set of biological pathways in which the expression profiles were altered upon deletion of Sirt1. Such pathways included cell motility, chemotaxis, cell adhesion, and cell cycle (Fig. 2B,S1C ). Additional pathway and enrichment analysis was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) database. These analyses confirmed similar biological pathways governed by endogenous Sirt1 in the prostate including autophagy, apoptosis, and cell proliferation (Fig. 2C) . Sirt1 regulated the expression of Atg4, Atg7, and Atg8 in the prostate. These genes are required for late-stage autophagy including phagophore elongation, maturation, and autophagosome vesicle formation (Fig. 2C ). This biological role for Sirt1 in the promotion of autophagy was further confirmed by ASSESS pathway analysis, as a defined set of genes up-regulated following rapamycin treatment and mTOR (mechanistic target of rapamycin) inhibition (known autophagic stimulants) were also promoted by Sirt1 in the prostate (Fig. S1C ).
SIRT1 Inhibits AR-Dependent Repression of Autophagy
In 
for the formation of autophagosomes and for the completion of macroautophagy. Additionally, the LC3-GFP fusion protein can be used as a surrogate measure of autophagy through the formation of "LC3 punctae or dots" (28) .
To validate our microarray results, AR-expressing prostate cancer cells (LNCaP) were treated with either control siRNA or siRNA directed against SIRT1. Whole cell lysates were subjected to immunoblotting for SIRT1 and autophagy markers, ATG4c, LC3-I, and LC3-II.
Following SIRT1 knockdown, the abundance of these proteins decreased suggesting that SIRT1 promotes autophagy in prostate cancer cells (Fig. 3A) . Western blots performed using protein previously described (29) . Cells were also co-transfected with GFP to confirm transfection efficiency (>80% GFP positive cells post-transfection) (Fig. 3G) .
Immunoblotting confirmed the induction of LC3-II by serum deprivation. SIRT1 transfection of LNCaP cells further enhanced the formation of LC3-II in both complete growth media and in serum-deprived media (Fig. 4A) . SIRT1 induced the abundance of the autophagyrelated proteins ATG5, ATG6 (Beclin1) and ATG9 (Data Not Shown). The SIRT1 antagonist Sirtinol enhanced DHT-mediated repression of autophagy (Fig. 4B) . Collectively, these studies demonstrate that SIRT1 antagonizes DHT-mediated repression of autophagy, an effect that can be abolished by Sirtinol-mediated SIRT1 inhibition.
The formation of acidic, vesicular organelles (AVOs) in the cell cytoplasm, which can be stained by acridine orange (AO) (22) , is an additional measure of autophagy. Punctate, To examine further the mechanism by which SIRT1 regulates autophagy in prostate cancer cells, LNCaP cells were transduced with either MSCV-IRES-GFP or MSCV-IRES-SIRT1-GFP retroviruses and subsequently sorted by GFP expression (Fig. 4C ). Cells were GFP sorted and stained with MDC or AO and analyzed by confocal microscopy. Cells transduced with SIRT1 exhibited heightened AVO formation in both the presence and absence of autophagic stimuli (serum) and androgens (Figs. S4D-F,S5,S6 ). Co-immunofluorescence for LC3, SIRT1 (Fig. 4D,E) , GFP, and IgG controls (Figs. S7A-D) was also performed on these cells in the presence and absence of autophagic stimuli (Hank's Balanced Buffer Solution, HBSS, Gibco/Invitrogen). HBSS was shown to increase the autophagic response as evident by an increase in LC3 positive staining (Fig. 4D,E) . This effect appears to be mediated at some level through SIRT1 as HBSS treatment stimulated SIRT1 expression in MSCV-IRES-GFP transduced cells (Fig. 4D) . The abundance of LC3 staining and severity of the autophagic response was enhanced in MSCV-IRES-SIRT1-GFP transduced cells (Fig. 4E) . Notably, HBSS treatment of these cells stimulated a shift of SIRT1 expression from a primarily nuclear distribution to a more uniform distribution throughout the nucleus and cytosol. This observation could be explained by the ability of HBSS to induce cellular stress, in turn triggering SIRT1 to transfer into the cytosol where it may deacetylate and activate late-stage autophagy related genes to finalize the induction of autophagy and protect the cell from stress.
LNCaP cells stably expressing either GFP (LNCaP-GFP) or the LC3-GFP fusion protein (LNCaP-LC3-GFP) were established. These cells were sequentially transfected with either pcDNA3 or SIRT1, treated with either vehicle or DHT, and analyzed by confocal microscopy for the appearance of GFP-positive, LC3 punctae (Fig. 5A-D) . SIRT1 induced the formation of LC3 punctae, which was reversed upon inhibition of SIRT1 with Sirtinol (Figs. 5A-D,6A,B) . -/-prostates demonstrate increased Ki67 staining, prostatic hyperplasia, and prostatic intraepithelial neoplasia. Sirt1 promoted autophagy in the prostate, functioning at the level of autophagosome maturation and vesicle formation (Fig. 7) . 
Gene expression analysis further demonstrated that loss of endogenous Sirt1 inhibited autophagy. At a higher level of resolution, our studies demonstrated that SIRT1 antagonized DHT-mediated inhibition of autophagy in the prostate. Autophagy allows for degradation of proteins and organelles (32, 33) and is induced by nutrient withdrawal, rapamycin (inhibition of mTOR signaling), and hormone signaling (PPARγ, ERα/Tamoxifen) (22) (36) . In Saccharomyces Cerevisiae, autophagy is essential for differentiation and sporulation (37) , and in Caenorhabditis Elegans, bec-1 (ATG6/VPS30/Beclin1) is essential for dauer diapause formation (38) . Mice defective in autophagy have shown defective tissue development as conditional Atg5
and Atg7 knockout mice demonstrate neuronal and hepatic abnormalities (39, 40) . Autophagy has also been implicated in tissue remodeling associated with duct formation in breast and prostate cells in vitro and in 3D matrigel (41) . Prostatic 3D cultures also form hollow, acinus-like structures that stain strongly for LC3 (42) . Autophagy has pro-survival and pro-death functions (43) . A pro-survival function for autophagy is evidenced by a loss of autophagy resulting in death of both C. Elegans and D. Melanogaster (37, 38) . In contrast, autophagy can also be pro- death. Knockdown of Atg's inhibits non-apoptotic cell death (44) . These studies suggest that physiological levels of autophagy are pro-survival, whereas an excessive level of autophagy promotes autophagic cell death (45) .
The role of autophagy in cancer was proposed over 20 years ago (46) . Autophagy appears to be essential for tumor suppression as well as for cell survival (47) . Autophagy plays a prosurvival function for cancer cells during nutrient deprivation or when apoptotic pathways are compromised, a phenotype often accompanied by inflammation. In contrast, upon disruption of tumor suppressors, autophagy adopts a pro-death role with apoptotic pathways (48) . In prostate, breast, ovarian, and lung cancer, loss of Beclin1 or inhibition of Beclin1 by the BCL-2 family of proteins causes defective autophagy, increased DNA damage, metabolic stress, and genomic instability. These cancers also display neoplastic changes and increased cell proliferation, unlike cells over-expressing Beclin1, which undergo apoptosis (49, 50) . Loss of PTEN, p53, ATG4, 
